ESOPJul 21, 2026, 04:07 PM
Madrigal Grants Equity Awards to 10 New Employees
AI Summary
Madrigal Pharmaceuticals granted equity inducement awards to ten new non-executive employees on July 15, 2026, under its 2025 Inducement Plan. These awards, approved by the independent Compensation Committee, include options to purchase 4,770 shares, 7,433 time-based restricted stock units, and 1,908 performance-based restricted stock units. The awards are intended to induce employees' acceptance of employment and are subject to continued employment and specific vesting schedules.
Key Highlights
- Equity awards granted to 10 new non-executive employees.
- Awards made under Madrigal’s 2025 Inducement Plan.
- Granted options to purchase 4,770 shares of common stock.
- Granted 7,433 time-based restricted stock units.
- Granted 1,908 performance-based restricted stock units.
- Options exercise price set at $550.25 per share.
- Options vest 25% on 1st anniversary, then 6.25% quarterly.
- RSUs vest in four equal installments over four years.
Price Impact
More from MDGL